tirzepatide overdose treatment and Graves Disease: Safety and Clinical Considerations Tirzepatide Overdose: Signs, Risks &

Potential clinical investigations may include: Comprehensive metabolic panel and hemoglobin A1c to assess diabetes control Hormone levels when clinically indicated (such as morning testosterone in men with symptoms of hypogonadism) Cardiovascular assessment, as erectile dysfunction can be an early marker of cardiovascular disease Screening for depression and anxiety, which frequently affect libido Pregnancy testing when appropriate Never discontinue semaglutide or adjust dosing without medical guidance

4 Interestingly, early trials suggested DPP-4 may affect the immune system due to inhibition of T-cell activity in vitro

While were still learning about their full range of effects, some reports suggest they may even help with addiction

The effects range from diminished energy and hydration to losing momentum on wellness goals

No, certain medical conditions and situations may make retatrutide unsafe